Trial
NCT02841540
A Study of H3B-8800 (RVT-2001) in Participants With Lower Risk Myelodysplastic Syndromes
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Hemavant Sciences GmbH
Collaborators
—
Condition
Leukemia, Myeloid, Acute
Intervention
H3B-8800 (RVT-2001)
Why stopped
The study was terminated after conducting an interim analysis of the available data where it became evident that the observed efficacy results were not in alignment with the initially set expectations.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-02-14